Presentation AHA 2018 PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure Presenter: Eric J Velazquez November 12, 2018
Presentation AHA 2018 Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial Presenter: Sotirios Tsimikas November 11, 2018
Presentation CDM 2018 Cardiovascular Outcomes Trials (CVOT): Latest Results and Recommendations Presenter: Dailey George October 12, 2018
Presentation TCT 2018 RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease Presenter: James B. Hermiller Jr, Hiroki Shiomi September 25, 2018
Presentation TCT 2018 OAC ALONE: Summary and Clinical Implications Presenter: John A. Bittl, David Erlinge, Takashi Kubo, Yukiko Nakano September 24, 2018
Presentation TCT 2018 LRP: Summary and Clinical Implications Presenter: John A. Bittl, David Erlinge, Takashi Kubo, Ron Waksman September 24, 2018
Presentation TCT 2018 Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now? Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Chandan Devireddy September 24, 2018
Presentation TCT 2018 ULTIMATE: Summary and Clinical Implications Presenter: John A. Bittl, David Erlinge, Takashi Kubo, Junjie Zhang September 24, 2018
Presentation TCT 2018 Alcohol-Mediated Renal Denervation Current Status and US Pivotal Trial Plans Presenter: Felix Mahfoud, Krishna J. Rocha-Singh September 24, 2018
Presentation TCT 2018 Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials) Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, David E. Kandzari September 24, 2018
Presentation TCT 2018 MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease Presenter: Jeroen J. Bax, Seung-Jung Park September 24, 2018
Presentation TCT 2018 SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results) Presenter: Jeroen J. Bax, Daniel J.F.M. Thuijs September 24, 2018
Presentation TCT 2018 PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions Presenter: Jeroen J. Bax, Gert Richardt September 24, 2018
Presentation TCT 2018 HighLife: Device Attributes, Implant Procedure, and Clinical Results Presenter: Michael J. Mack, David W.M. Muller, Ruediger S. Lange September 24, 2018
Presentation TCT 2018 Tiara: Device Attributes, Implant Procedure, and Clinical Results Presenter: Michael J. Mack, David W.M. Muller, Shmuel Banai September 24, 2018
Presentation TCT 2018 Tendyne: Device Attributes, Implant Procedure, Clinical Results and SUMMIT Design and Status Presenter: Michael J. Mack, David W.M. Muller, Gorav Ailawadi September 24, 2018
Presentation TCT 2018 GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Patrick W. Serruys September 24, 2018
Presentation TCT 2018 Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status Presenter: Michael J. Mack, David W.M. Muller, Michael J. Reardon September 24, 2018
Presentation TCT 2018 ESC 2018 Late Breaking Trial #2 - MitraFR: What I Liked and What I Question Presenter: Deepak L. Bhatt, Gregg W. Stone, Stephan Windecker September 23, 2018
Presentation TCT 2018 ESC 2018 Late Breaking Trial #1 Global Leaders: What I Liked and What I Question Presenter: Deepak L. Bhatt, Gregg W. Stone, Giuseppe Biondi-Zoccai September 23, 2018